VLRX - バレリタス・ホ―ルディングス (Valeritas Holdings Inc.) バレリタス・ホ―ルディングス

 VLRXのチャート


 VLRXの企業情報

symbol VLRx
会社名 Valeritas Holdings Inc (バレリタス・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種    医療関連(Health Care)
概要 事業概要 --   バレリタス・ホ―ルディングスは米国の医療技術企業。主に、2型糖尿病患者向けの製品の設計、開発、商業化に従事。主力製品には、24時間装着可能なパッチタイプのインスリン送達デバイス「V-Go」がある。また、針を用いない薬物送達システムや極微針パッチなどを開発。本社はニュ―ジャ―ジ―州ブリッジウォ―タ―。   Valeritas Holdings, Inc. is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.
本社所在地 750 Route 202 South Suite 600 Bridgewater NJ 08807 USA
代表者氏名
代表者役職名
電話番号
設立年月日 41760
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 103人
url www.valeritas.com
nasdaq_url https://www.nasdaq.com/symbol/vlrx
adr_tso
EBITDA EBITDA ー
終値(lastsale) 1.51
時価総額(marketcap) 37534068.49
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 VLRXのテクニカル分析


 VLRXのニュース

   Valeritas Rallies On Positive Preclinical Data For CBD Delivery Using Wearable Device  2019/07/30 13:11:19 Benzinga
Valeritas Holdings Inc (NASDAQ: VLRX ) shares have shed more than 61% in the year-to-date period. The stock is picking up some momentum Tuesday following a pre-clinical data readout from the medical technology company. What Happened Valeritas, which makes the V-Go – Wearable Insulin Delivery Device using its proprietary h-Patch technology, announced positive results from a preclinical pharmacokinetic study of cannabidiol subcutaneous infusion with two dosing regimens delivered using its proprietary h-Patch wearable drug delivery device. The study evaluated CBD delivered over a single 24-hour period using the h-Patch, with two doses: 40mg/24 hour and 76mg/24 hour tested using the patch. The pharmacokinetics … Full story available on Benzinga.com
   Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary  2019/07/10 12:36:13 Benzinga
Valeritas Holdings (NASDAQ: VLRX ) shares are trading higher after the company on Tuesday afternoon announced its V-Go wearable insulin device has been adopted on multiple managed care formularies. The V-Go is a disposable device for the delivery of … Full story available on Benzinga.com
   AMRN, CARA, ANF and GOOS among midday movers  2019/05/29 16:39:18 Seeking Alpha
   Amarin and Cara Therapeutics among healthcare gainers; Sorrento Therapeutics leads the losers  2019/05/29 15:01:56 Seeking Alpha
   ARMP, BIOC among top gainers  2019/05/28 13:25:43 Seeking Alpha
   Valeritas Rallies On Positive Preclinical Data For CBD Delivery Using Wearable Device  2019/07/30 13:11:19 Benzinga
Valeritas Holdings Inc (NASDAQ: VLRX ) shares have shed more than 61% in the year-to-date period. The stock is picking up some momentum Tuesday following a pre-clinical data readout from the medical technology company. What Happened Valeritas, which makes the V-Go – Wearable Insulin Delivery Device using its proprietary h-Patch technology, announced positive results from a preclinical pharmacokinetic study of cannabidiol subcutaneous infusion with two dosing regimens delivered using its proprietary h-Patch wearable drug delivery device. The study evaluated CBD delivered over a single 24-hour period using the h-Patch, with two doses: 40mg/24 hour and 76mg/24 hour tested using the patch. The pharmacokinetics … Full story available on Benzinga.com
   Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary  2019/07/10 12:36:13 Benzinga
Valeritas Holdings (NASDAQ: VLRX ) shares are trading higher after the company on Tuesday afternoon announced its V-Go wearable insulin device has been adopted on multiple managed care formularies. The V-Go is a disposable device for the delivery of … Full story available on Benzinga.com
   AMRN, CARA, ANF and GOOS among midday movers  2019/05/29 16:39:18 Seeking Alpha
   Amarin and Cara Therapeutics among healthcare gainers; Sorrento Therapeutics leads the losers  2019/05/29 15:01:56 Seeking Alpha
   ARMP, BIOC among top gainers  2019/05/28 13:25:43 Seeking Alpha
   Valeritas' V-Go preferred on Humana Part D formularies  2019-01-03
Valeritas Holdings (NASDAQ: VLRX ) announces that Humanahas given V-Go Preferred status on its Part D formularies. More news on: Valeritas Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more …

 関連キーワード  (― 米国株 バレリタス・ホ―ルディングス VLRX Valeritas Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)